Evidence map›Paper›PMID 36971980›Full record

ArticleJournal of fluorescence2023

Biological and Sensing Applications of a Few 1,3,4-Oxadiazole Based Donor-Acceptor Systems.

T M Remya, T M Asha, Ayswaria Deepti, Prabha Prakash, P S Baby Chakrapani, Unnikrishnan P A, Abdullah G Al-Sehemi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

T M Remya *Department of Applied Chemistry, Cochin University of Science and Technology, 682 022, Kalamassery, Kochi, Kerala, India. remyatm1991@gmail.com.
T M Asha *Department of Chemical Oceanography, School of Marine Sciences, Cochin University of Science and Technology, Foreshore Rd, 682 016, Pallimukku, Kochi, Kerala, India.
Ayswaria DeeptiCentre for Neuroscience, Department of Biotechnology, Cochin University of Science and Technology, 682 022, Kochi, Kerala, India.
Prabha PrakashCentre for Neuroscience, Department of Biotechnology, Cochin University of Science and Technology, 682 022, Kochi, Kerala, India.
P S Baby ChakrapaniCentre for Neuroscience, Department of Biotechnology, Cochin University of Science and Technology, 682 022, Kochi, Kerala, India.
Unnikrishnan P ADepartment of Applied Chemistry, Cochin University of Science and Technology, 682 022, Kalamassery, Kochi, Kerala, India.
Abdullah G Al-SehemiDepartment of Chemistry, Faculty of Science, King Khalid University, 61413, Abha, Saudi Arabia.
Cochin University of Science and Technology · INKing Khalid University · SA

Funding

Deanship of Scientific Research at King Khalid University R.G.P.2/215/44
6 · The paper itself

Abstract

1,3,4-Oxadiazole pharmacophore is still considered a viable biologically active scaffold for the synthesis of more effectual and broad-spectrum antimicrobial agents. Therefore, the present study is based on five 1,3,4-oxadiazole target structures, viz., CAROT, CAROP, CARON (D-A-D-A systems) and NOPON and BOPOB (D-A-D-A-D systems) bearing various bioactive heterocyclic moieties relevant to potential biological activities. Three of the compounds, CARON, NOPON and BOPOB were assessed in-vitro for their efficacy as antimicrobial agents against gram positive (Staphylococcus aureus and Bacillus cereus) and gram negative (Escherichia coli and Klebsiella pneumonia) bacteria; and two fungi, Aspergillus niger and Candida albicans; also, as an anti-tuberculosis agent against Mycobacterium tuberculosis. Most of the tested compounds displayed promising antimicrobial activity, especially CARON which was then analyzed for the minimum inhibitory concentration (MIC) studies. Similarly, NOPON portrayed the highest anti-TB activity among the studied compounds. Consequently, to justify the detected anti-TB activity of these compounds and to recognize the binding mode and important interactions between the compounds and the ligand binding site of the potential target, these compounds were docked into the active binding site of cytochrome P450 CYP121 enzyme of Mycobacterium tuberculosis, 3G5H. The docking results were in good agreement with the result of in-vitro studies. In addition, all the five compounds were tested for their cell viability and have been investigated for cell labeling applications. To conclude, one of the target compounds, CAROT was used for the selective recognition of cyanide ion by 'turn-off' fluorescent sensing technique. The entire sensing activity was examined by spectrofluorometric method and MALDI spectral studies. The limit of detection obtained was 0.14 µM.

Indexed as

Anti-Infective AgentsAnti-Bacterial AgentsAntifungal AgentsBacteriaFungiMicrobial Sensitivity TestsOxadiazolesStructure-Activity Relationship1,3,4-oxadiazoleAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsOxadiazoles1,3,4-oxadiazoleAntimicrobial studiesAnti-tuberculosisCell stainingCyanide sensingPhenothiazine

Identifiers

PMID36971980
OpenAlexW4361008521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.